November 2005 Dear Health Care Professional: Ortho Biotech Clinical Affairs, LLC (“Ortho Biotech”) wishes to inform you that sections of the product prescribing information for PROCRIT® (epoetin alfa) have been upda

First Page		Document Content
Erythropoiesis-stimulating agents Growth factors Hematopathology Amgen Erythropoietin Immunogenicity Anemia Pure red cell aplasia Epoetin alfa Medicine Biology Hematology		November 2005 Dear Health Care Professional: Ortho Biotech Clinical Affairs, LLC (“Ortho Biotech”) wishes to inform you that sections of the product prescribing information for PROCRIT® (epoetin alfa) have been upda Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 167,40 KB Share Document on Facebook

	Drug Safety Update Latest advice for medicines users The monthly newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines Volume 8, Issue 10 Ma DocID: 19EOH - View Document
	Considerations on WHO’s BQ Proposal Joerg Windisch, PhD, Chair European Biosimilars Group (EBG) Chief Science Officer, Sandoz Biopharmaceuticals 60th INN Consultation WHO, Geneva, April 13th, 2015 DocID: 155OS - View Document
	A S U P P L E M E N T TO DIAGNOSIS AND MANAGEMENT OF ANEMIA IN LONG-TERM CARE HIGHLIGHTS OF A SYMPOSIUM DocID: 14Pur - View Document
	Reprint from January 8, 2007 BioCentury THE BERNSTEIN REPORT ARTICLE REPRINT DocID: 13F1b - View Document
	REPRINTED WITH PERMISSION Business Day DocID: 13gi3 - View Document